UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Annals of oncology, 2017-02, Vol.28 (2), p.218-227

2017

Volltextzugriff (PDF)

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network

Annals of oncology, 2013-08, Vol.24 (8), p.2119-2123

2013

Volltextzugriff (PDF)

OUTCOMES OF THE TREATMENT AFTER ANTI‐CD19 CAR‐T THERAPY FAILURE IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA—ANALYSIS OF DATA FROM THE CZECH REPUBLIC

Hematological oncology, 2023-06, Vol.41 (S2), p.792-793

2023

Volltextzugriff (PDF)

Venous thromboembolism in patients with chronic lymphocytic leukemia

Thrombosis research, 2015-12, Vol.136 (6), p.1082-1086

2015

Volltextzugriff (PDF)

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome

Leukemia research reports, 2021-01, Vol.16, p.100274, Article 100274

2021

Volltextzugriff (PDF)

Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies

Journal of Immunology Research, 2017-01, Vol.2017, p.7304658-8

2017

Volltextzugriff (PDF)

P676: LOW‐DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP

HemaSphere, 2022-06, Vol.6, p.574-575

2022

Volltextzugriff (PDF)

Why R-CHOP for first line treatment of chronic lymphocytic leukemia?

International journal of laboratory hematology, 2007-12, Vol.29 (6), p.478-479

Smolej, L.

2007

Volltextzugriff (PDF)

Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia

Hematology (Luxembourg), 2012-09, Vol.17 (5), p.268-274

2012

Volltextzugriff (PDF)

Burkitt lymphoma–multicenter retrospective data analysis from the Czech Lymphoma Study Group–NiHiL project

Hematological oncology, 2017-06, Vol.35 (S2), p.342-343

2017

Volltextzugriff (PDF)

Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-12, Vol.116 (12), p.1058-1062

2008

Volltextzugriff (PDF)

Therapeutic Options for "Slow go" Patients with Chronic Lymphocytic Leukemia

Klinická onkologie, 2015-01, Vol.28 Suppl 3, p.3S30-3S38

Smolej, L

2015

Volltextzugriff (PDF)

Therapeutic Options for "Slow go" Patients with Chronic Lymphocytic Leukemia

Klinická onkologie, 2015-10, Vol.28 Suppl 3 (Suppl 3), p.3S30-3S38

Smolej, L

2015

Volltextzugriff (PDF)

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia

Neoplasma, 2014, Vol.61 (5), p.585

2014

Volltextzugriff (PDF)

5.45 Rituximab Infusion-Related Toxicity In Patients With CLL

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S275-S275

2011

Volltextzugriff (PDF)

Léčebný přístup k vysoce rizikové lymfocytární leukemii: alogenní transplantace krvetvorných bunĕk je jedinou šancí na trvalé vyléčení - editorial

Vnitřní lékar̆stvĭ, 2013-10, Vol.59 (10), p.872

Smolej, L

2013

Volltextzugriff (PDF)

Not Available

Vnitřní lékar̆stvĭ, 2013-10, Vol.59 (10), p.872-873

Smolej, L

2013

Volltextzugriff (PDF)

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab

Pharmacogenomics and personalized medicine, 2015-01, Vol.8 (default), p.1-7

Smolej, Lukáš

2015

Volltextzugriff (PDF)

Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells

Neoplasma, 2011, Vol.58 (2), p.140

2011

Volltextzugriff (PDF)

Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features

Hematology (Luxembourg), 2010-08, Vol.15 (4), p.210-214

2010

Volltextzugriff (PDF)

Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease

International journal of laboratory hematology, 2008-06, Vol.30 (3), p.259-260

2008

Volltextzugriff (PDF)

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

British journal of haematology, 2015-07, Vol.170 (1), p.40-49

2015

Volltextzugriff (PDF)

Isotype class switching after transplantation in multiple myeloma

Neoplasma, 2007, Vol.54 (3), p.225

2007

Volltextzugriff (PDF)

Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemiaa

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-12, Vol.116, p.1058-1062

2008

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(47)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Male
(33)
Female
(31)
Adult
(25)
Middle Aged
(25)
Aged
(24)
Aged, 80 And Over
(16)
Prognosis
(14)
Anthropology
(13)
Croatia
(11)
Hematology
(11)
Biological And Medical Sciences
(10)
Chronic Lymphocytic Leukemia
(9)
Medical Sciences
(9)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(8)
Adolescent
(7)
Anthropometry
(7)
Croatia - Epidemiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network

OUTCOMES OF THE TREATMENT AFTER ANTI‐CD19 CAR‐T THERAPY FAILURE IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA—ANALYSIS OF DATA FROM THE CZECH REPUBLIC

Venous thromboembolism in patients with chronic lymphocytic leukemia

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome

Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies

P676: LOW‐DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP

Why R-CHOP for first line treatment of chronic lymphocytic leukemia?

Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia

Burkitt lymphoma–multicenter retrospective data analysis from the Czech Lymphoma Study Group–NiHiL project

Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia

Therapeutic Options for "Slow go" Patients with Chronic Lymphocytic Leukemia

Therapeutic Options for "Slow go" Patients with Chronic Lymphocytic Leukemia

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia

5.45 Rituximab Infusion-Related Toxicity In Patients With CLL

Léčebný přístup k vysoce rizikové lymfocytární leukemii: alogenní transplantace krvetvorných bunĕk je jedinou šancí na trvalé vyléčení - editorial

Not Available

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab

Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells

Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features

Expression of ZAP-70 in patients with chronic lymphocytic leukemia may change significantly during the course of the disease

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients

Isotype class switching after transplantation in multiple myeloma

Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemiaa

Suchergebnisse filtern